2011
DOI: 10.1097/pas.0b013e31822895e5
|View full text |Cite
|
Sign up to set email alerts
|

Immunoexpression Status and Prognostic Value of mTOR and Hypoxia-Induced Pathway Members in Primary and Metastatic Clear Cell Renal Cell Carcinomas

Abstract: The need for effective targeted therapies for renal cell carcinomas (RCC) has fueled the interest for understanding molecular pathways involved in the oncogenesis of kidney tumors. Aiming to analyze the expression status and prognostic significance of mTOR and hypoxia-induced pathway members in patients with clear cell RCC (ccRCC) tissue microarrays were constructed from 135 primary and 41 metastatic ccRCC. Immunoexpression levels were compared and correlated with clinicopathologic parameters and outcome. PTEN… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
43
1

Year Published

2012
2012
2022
2022

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 72 publications
(50 citation statements)
references
References 49 publications
6
43
1
Order By: Relevance
“…In ccRCC, carbonic anhydrase 9 (CA9) is one of the most studied and most promising biomarkers. 51 Patients with low CA9 expression were reported to have worse prognosis; in metastatic disease, high CA9 expression was associated with better survival. 51 SPAG4 could be a clinically useful biomarker in combination with other biomarkers, such as CA9.…”
Section: Regulation Of Cytokinesis By Spag4mentioning
confidence: 98%
“…In ccRCC, carbonic anhydrase 9 (CA9) is one of the most studied and most promising biomarkers. 51 Patients with low CA9 expression were reported to have worse prognosis; in metastatic disease, high CA9 expression was associated with better survival. 51 SPAG4 could be a clinically useful biomarker in combination with other biomarkers, such as CA9.…”
Section: Regulation Of Cytokinesis By Spag4mentioning
confidence: 98%
“…Mutant p53 expression was also significantly higher in metastatic tumors compared with primary tumors (51.8% vs. 22.8%) in a study by Zigeuner et al (21), and p53 overexpression (risk ratio, 2.9; 95% confidence interval, 1.3-6.7; P=0.01) was revealed to be an independent prognostic factor for metastasis-free survival, although the specimens were not matched. In a study of mammalian target of rapamycin-and hypoxia-induced pathway members, which included 135 primary RCCs and 41 unrelated metastases, differential global patterns of expression were measured (22). The levels of p-AKT, p-S6, 4EBP1 and c-myc were higher in metastatic lesions compared with primary tissues.…”
mentioning
confidence: 99%
“…Furthermore, HIF-1α proved to be a prognostic marker for ccRCC . 16 Based on these current findings, it appears that HIF-1α is more important than HIF-2α in ccRCC, although HIF-2α is co-expressed frequently with HIF-1α and suggests its potential influence in ccRCC. In a recent xenograft study with human RCC cell lines, loss of HIF-2α expression impaired tumor growth , whereas loss of HIF-1α expression increased tumor growth.…”
Section: Discussionmentioning
confidence: 56%
“…The greater expression of HIF-1α in metastatic foci than in primary ccRCC is in agreement with a previous study in which levels of HIF-1α were higher in metastatic than in primary ccRCC. 16 The roles of HIF-1α and HIF-2α are not clearly distinct in ccRCC. In a previous transgenic study, stable expression of HIF-1α, but not HIF-2α, induced ccRCC in mice.…”
Section: Discussionmentioning
confidence: 99%